Background: Although botulinum toxin (BoNT/A) injected into the detrusor muscle improves
overactive bladder symptoms in patients with neurogenic detrusor overactivity, how it does …

Study design: Bladder capacity, bladder compliance, the volume of the first overactive
contraction, maximal volume during cystometry (CMG) and the vesicoureteral reflux, bladder …

The recent increase in the use of sacral neuromodulation (SN) for the treatment of detrusor
overactivity has coincided with improved knowledge of micturition physiology and …

Study design: Animal proof of principle study. Objectives: To determine whether
capromorelin, a compound that causes defecation by stimulating ghrelin receptors within the …

The use of Botulinum neurotoxin type A (BoNT/A) in the lower urinary tract was pioneered as
early as 20 years ago with injections into the urethral sphincter reducing bladder voiding …

PURPOSE: Spinal cord injury induces functional and morphological changes in bladder
afferent pathways. However, direct evidence for changes in the excitability of afferent nerve …

Purpose Detrusor–sphincter dyssynergia (DSD) and bladder neck dysfunction (BND) may
cause voiding dysfunction in patients with spinal cord injury (SCI). We report the surgical …

Interstitial cystitis or bladder pain syndrome (IC/BPS) is a disease of unknown etiology
manifested with bladder pain and frequency urgency symptoms. Although several …

Vesico-urethral dysfunction is a major problem in daily medical practice due to its
psychological disturbances, its social costs and its high impact on quality of life. Recently …

目的: 探讨电针次髎对逼尿肌反射亢进的效应及作用机理. 方法: 成年雌性SD 大鼠44 只,
脊髓横断术后纳入37 只, 分为手术后电针组16 只, 手术后模型组16 只, 正常组(假手术组) 5 只 …